Antimicrobial resistance (AMR) is one of today’s major global public health challenges. The number of drug resistant pathogens is increasing worldwide at an alarming rate, placing a heavy burden on healthcare systems.1,2 Yet despite this, no new classes of antimicrobials have been introduced in the last 30 years.

Join for free to read